Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SFTPB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RBM48 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCL2L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHEB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCL19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF77 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZER1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01487 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IL22RA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABHD11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRND - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00334 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STAMBPL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
QRSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on